Sandbox:risk: Difference between revisions

← Older edit

VisualWikitext

Latest revision as of 03:06, 10 October 2015

INNS stage 2A/2B, Stage 3 , Stage 4 or Stage 4S
Irrespective of age
Irrespective of grade
MYCN amplified

INSS stage 3
>547 days of age
Unfavorable histology
MYCN not amplified

Intermediate risk neuroblastoma patients (group 2)

INNS stage 4
365-547 days of age
Unfavorable histology
DNA index=1
MYCN not amplified

Symptomatic INNS stage 4
>547 days of age
Irrespective grade
Irrespective MYCN amplification state

High risk neuroblastoma patients include:

Patients with stage 2A/2B, 3, 4, or 4S tumor, irrespective of the age, irrespective of the grade, MYCN amplified
Patients with stage 3 tumor, ≥ 547 days of age, unfavorable histology, MYCN not amplified
Patients with stage 4 tumor, 365-547 days of age, unfavorable histology, DNA index=1, MYCN not amplified
Patients with stage 4 tumor, >547 days of age, irrespective the grade, MYCN amplification state

@@ Line 1: / Line 1: @@
 {{familytree/start |summary=PE diagnosis Algorithm.}}
-{{familytree | | | | | | | | | |,|-| A01 | | | | |A01=
+{{familytree | | | | | | | | |,|-| A01 | | | | |A01=
-'''INSS stage 1'''<br>'''Irrespective of age'''<br>'''Irrespective of grade'''<br>'''Irrespective of molecular pathway'''}}
+<div style="width: 20em; padding:0em;text-align:left">
-{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
+*'''INNS stage 2A/2B, Stage 3 , Stage 4 or Stage 4S'''<br>
-{{familytree | | | | | | C01 |-|+|-| B01 | | | | |C01=Low risk neuroblastoma patients  |B01= }}
+*'''Irrespective of age'''<br>
-{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | }}
+*'''Irrespective of grade'''<br>
-{{familytree | | | | | | | | | |`|-| C02 | | | | | | |C02= }}
+*'''''MYCN'' amplified'''</div>}}
+{{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | | }}
+{{familytree | | | | | | | | |)|-| B01 | | | | ||B01=<div style="width: 20em; padding:0em;text-align:left">
+*'''INSS stage 3'''<br>
+*'''>547 days of age'''<br>
+*'''Unfavorable histology'''<br>
+*'''''MYCN'' not amplified'''</div>}}
+{{familytree | | | | | C01 |-|(| | | | | |C01=<div style="width: 20em; padding:1em;text-align:center">'''Intermediate risk neuroblastoma patients (group 2)'''</div> | | | | | | | | | | | | }}
+{{familytree | | | | | | | | |)|-| C02 | | | | | | |C02=<div style="width: 20em; padding:0em;text-align:left">
+*'''INNS stage 4'''<br>
+*'''365-547 days of age'''<br>
+*'''Unfavorable histology'''<br>
+*'''DNA index=1'''<br>
+*'''''MYCN'' not amplified'''</div>}}
+{{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | }}
+{{familytree | | | | | | | | |`|-| C02 | | | | | | |C02=<div style="width: 20em; padding:0em;text-align:left">
+*'''Symptomatic INNS stage 4'''<br>
+*'''>547 days of age'''<br>
+*'''Irrespective grade'''<br>
+*'''Irrespective ''MYCN'' amplification state'''</div>}}
+{{familytree/end}}
-* '''Low risk neuroblastoma patients''' include:
-:* Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway
-:* Patients with stage 2A/2B (>50% resected), irrespective of age, irrespective of the grade, ''MYCN''not amplified
-:* Patients with Stage 4S, <365 days of age, favorable histology, DNA index >1 , ''MYCN'' not amplified
+* '''High risk neuroblastoma patients''' include:
+:* Patients with stage 2A/2B, 3, 4, or 4S tumor, irrespective of the age, irrespective of the grade, ''MYCN'' amplified
+:* Patients with stage 3 tumor, ≥ 547 days of age, unfavorable histology, ''MYCN'' not amplified
+:* Patients with stage 4 tumor, 365-547 days of age, unfavorable histology, DNA index=1, ''MYCN'' not amplified
+:* Patients with stage 4 tumor, >547 days of age, irrespective the grade, ''MYCN'' amplification state

Sandbox:risk: Difference between revisions

Latest revision as of 03:06, 10 October 2015

Navigation menu

Search